Brain Stimulation Plus Rehabilitation: Where Stroke Recovery Stands

Physiotherapy after stroke rests on a genuine mechanism: intensive practice drives experience-dependent neuroplasticity. The problem is well documented in the literature. Recovery frequently plateaus despite intensive training.

That gap is what a growing body of 2025 and 2026 research is trying to close, by pairing rehabilitation with non-invasive brain stimulation.

The logic: prime the cortex, then train it

Non-invasive brain stimulation — transcranial magnetic stimulation and transcranial direct current stimulation being the two main families — can temporarily alter cortical excitability. The hypothesis is that if you make a region more responsive to input, practice delivered immediately afterwards should produce more learning.

A systematized review of non-invasive brain stimulation integrated with post-stroke rehabilitation frames this as a synergy question: stimulation may enhance cortical excitability and increase responsiveness to motor practice, but the review was undertaken precisely because the extent of that added benefit remained unclear across randomised trials.

What the recent trials found

Theta burst stimulation with task training. A pilot randomised controlled trial of intermittent theta burst stimulation combined with task-oriented training in subacute stroke reported that the combination was safe and feasible, with preliminary evidence of better upper-limb recovery, measured by the Fugl-Meyer Assessment, than training alone. The same study is explicit that this is a pilot: it establishes feasibility and a signal, not a proven effect.

Direct current stimulation with gait training. A randomised controlled trial of transcranial direct current stimulation paired with gait-oriented motor training in subacute stroke reported significantly greater improvements in the intervention group across primary and secondary outcomes, with moderate-to-large effect sizes, and a positive correlation between balance gains and the measured outcome changes.

Home-based device stimulation. The EMAGINE randomised clinical trial, published in JAMA Network Open, tested electromagnetic stimulation delivered through a brain-computer-interface-based device paired with a functional, repetitive, home-based program in people with ischaemic stroke, comparing active against sham stimulation.

Earlier and more specific targets. Protocols are also moving earlier and more precisely: a multicentre trial design for low-frequency deep transcranial magnetic stimulation within 48 hours of acute ischaemic stroke, and a multicentre double-blind randomised trial of cerebellar theta burst stimulation for post-stroke cognitive impairment, both test more targeted hypotheses than the first generation of studies.

What is still missing

Several questions have not been answered, and they are the ones that determine whether this reaches routine care.

• Dose. A dedicated protocol paper for optimising non-invasive brain stimulation in post-stroke rehabilitation exists because the optimal dosing is still an open research question.
• Who responds. Trials recruit broad populations; individual response is variable and not yet predictable.
• durability. Several studies measure outcomes immediately after the intervention. Whether gains persist months later is a separate question.
• Effect size over sham. The sham-controlled trials matter most, because expectation and extra therapist attention are real confounders in any stimulation study.

A fair summary

Pairing stimulation with rehabilitation is one of the more plausible applications of neuroplasticity research in clinical medicine, and the 2025 and 2026 trials have strengthened the safety and feasibility case considerably. It is not yet an established treatment. The honest description is a promising research program in the phase where effect sizes are still being established.

This article is educational and is not medical advice. Stroke rehabilitation decisions belong with your treating clinician.